GORE® DrySeal Flex Introducer Sheath Advances Care through Access
FLAGSTAFF, Ariz. W. L. Gore & Associates, Inc. (Gore) today announced the commercial availability of the GORE® DrySeal Flex Introducer Sheath, after recently gaining clearance for use by...
View ArticleGORE® DrySeal Flex Introducer Sheathはアクセス改善で治療を前進
米アリゾナ州フラッグスタッフ (ビジネスワイヤ) — W. L. Gore & Associates, Inc.(ゴア)は本日、米国・欧州・カナダ・オーストラリアの規制当局から最近承認されたことを受け、GORE® DrySeal Flex Introducer...
View ArticleGORE® DrySeal Flex导引器套管可简化路径以促进治疗
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布,GORE® DrySeal Flex导引器套管最近已获得美国、欧洲、加拿大和澳大利亚监管部门的核准,开始市售。该器械旨在凭借提升的弯曲度、抗扭曲性和亲水涂层的独特组合,来简化血管内修复手术期间至高难度解剖部位和旁支血管(例如髂总动脉)的路径。 Smart...
View ArticleCook Medical Names Jean-Marc Creissel Vice President of Operations in Greater...
BLOOMINGTON, Ind. Cook Medical is pleased to announce that Jean-Marc Creissel has been named vice president of operations for the greater China region. In his new role, Creissel will work with the...
View ArticleAncillare’s Peter Knapp to Kick off “Innovating the Supply Chain” at the...
HORSHAM, Pa. Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain management services for pharmaceutical, biotechnology, contract research and medical research...
View ArticleIMS Health和昆泰公布合并公司关键高管名单
康涅狄格州丹伯里和北卡罗莱纳州三角研究园 (美国商业资讯)–IMS Health Holdings, Inc. (NYSE:IMS) 和昆泰跨国控股公司(Quintiles Transnational Holdings Inc., NYSE:Q)今日公布合并完成后的昆泰IMS未来公司领导团队关键高管名单。 董事长兼首席执行官Ari...
View ArticleIMSヘルスとクインタイルズが合併会社の主要な役員を発表
米コネティカット州ダンバリー & 米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ) — IMSヘルス・ホールディングス・インク(NYSE:IMS)とクインタイルズ・トランスナショナル・ホールディングス・インク(NYSE:Q)は本日、合併完了を前提とし、今後のクインタイルズIMSコーポレート・リーダーシップチームの主要な上級経営陣を発表しました。...
View ArticleThe 15th Endocrine Regulations Prize of the Fondation IPSEN is Awarded to...
PARIS The Fondation IPSEN Endocrine Regulations Prize will be awarded this year at the ICE-CSE (International Congress of Endocrinology – Chinese Society of Endocrinology), in Beijing on September...
View ArticleThe IMS Institute for Healthcare Informatics Launches Asia Branch
SINGAPORE The IMS Institute for Healthcare Informatics today announced the launch of a new branch focused on supporting improved health outcomes across Asia. Based in Singapore, the team will forge...
View ArticleNeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China
WALTHAM, Mass. NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the State Intellectual Property Office of the People’s Republic of China has issued Chinese Patent No. ZL20118055305.7 for the...
View ArticleTakeda to develop Zika Vaccine with up to $312 million in funding from US...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that BARDA, the Biomedical Advanced Research and Development Authority, has selected Takeda’s Vaccine...
View ArticleReSound®重返在柏林举办的全球最大的消费类电子产品展览会,展示最先进的听力解决方案
柏林 (美国商业资讯)–本周,ReSound将重返全球最大的国际消费类电子产品展览会IFA,重点展示其屡获殊荣的智能助听器(Smart Hearing),同时协助主持讨论,探讨如何为听力医疗保健专业人员提供支持,其目的旨在让听力损失患者在试戴过程和日常生活中获得最高的满意度。全球有5亿多人饱受听力损失之苦,其中包括1,300万至1,500万德国人。...
View ArticleAlvogen Launches First Generic Equivalent of CopaxoneTM in Europe
PINE BROOK, N.J. Alvogen today announced the launch of RemurelTM (glatiramer acetate), the first generic equivalent of CopaxoneTM in Central and Eastern Europe. The product will be marketed as a...
View ArticleWOUNDCHEK™ Protease Status receives market clearance in Australia
FALL RIVER, Mass. WOUNDCHEK™ Laboratories announced today that WOUNDCHEK™ Protease Status, the world’s first point of care wound diagnostic for chronic wounds, has received market clearance from the...
View Articleサンバイオ、シニア・バイスプレジデント(人事担当)にグレッグ・ギラスが就任
米国カリフォルニア州マウンテンビュー (ビジネスワイヤ) — 再生細胞薬の開発・製造を手掛けるサンバイオ(サンバイオ株式会社及びその子会社であるSanBio Inc.を含むサンバイオグループ2社を指します。)は、今般、シニア・バイスプレジデント(人事担当)にグレッグ・ギラス(Greg...
View ArticleCertara Acquires d3 Medicine
PRINCETON, N.J. Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it has...
View ArticleKansas University Medical Center and Baylor Scott & White Research Institute...
SEATTLE Nativis, Inc., a clinical stage life sciences bio-electronics company developing non-invasive, medical device treatments for cancers and other serious diseases, today announced its latest...
View ArticleNoven Announces Appointment of Jeff Mihm to Its Board of Directors
MIAMI & NEW YORK Noven Pharmaceuticals, Inc. today announced the appointment of Jeff Mihm to its Board of Directors, effective immediately. Noven is a stand-alone operating subsidiary of...
View ArticleTakeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study...
View Article